Altium Capital Management LP Phasebio Pharmaceuticals Inc C Call Options Transaction History
Altium Capital Management LP
- $628 Million
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|